[1]WU Xinyu,HUANG Xiang.Efficiency and safety of Eribulin in patients with HER2 negative metastatic breast cancer: a real world study[J].Acta Universitatis Medicinalis Nanjing,2023(2):236-242.

[2]Tolerability and activity of trastuzumab in elderly patients with HER2-overexpressing metastatic breast cancer[J].Annals of oncology

[3]Herceptin as a single agent in patients with HER2 overexpressing metastatic breast cancer[J].Chinese Journal of Oncology

[4]Gonzalez-Angulo Ana Maria.Importance of accurate HER2 testing in patients with metastatic breast cancer[J].Clinical advances in hematology & oncology : H&O,2010,8(12):873-874.

[5]O'Malley Frances P,Thomson Tom,Julian Jim,Have Cherry,Cosby Roxanne,Crosby Roxanne,Gelmon Karen,Andrulis Irene,Whelan Tim.HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab[J].Archives of pathology & laboratory medicine,2008,132(1):61-65.

[6]Bender Eric.Dual HER2 blockade slows metastatic breast cancer[J].Cancer discovery,2012,2(1):OF4.

[7]Naoki Hayashi,Seigo Nakamura,Yasuharu Tokuda,Hiroshi Yagata,Atsushi Yoshida,Hidekazu Ota,Gabriel N. Hortobagyi,Massimo Cristofanilli,Naoto T. Ueno.Serum HER2 levels determined by two methods in patients with metastatic breast cancer[J].International journal of clinical oncology / Japan Society of Clinical Oncology,2012,17(1):55-62.

[8]Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer[J].Critical reviews in oncology/hematology

[9]Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients[J].Expert review of anticancer therapy

[10]WANG Tao,JIANG Ze-fei,SONG San-tai,LIU Xiao-qing,YU Jing-xin,LIU Fang,YAN Min.Herceptin as a single agent in patients with HER2 overexpressing metastatic breast cancer[J].Chinese Journal of Oncology,2004,26(7).

[11]贾晓晨,孟文静,何丽宏,贾勇圣,佟仲生.Sorafenib combined with chemotherapy for patients with HER2 negative metastatic breast cancer:A Meta-analysis[J].Chinese Journal of Cancer Prevention and Treatment,2017(7):486-491.

[12]Tanya Repka,Elena G Chiorean,Juliette Gay,Katherine E Herwig,Virginia K Kohl,Douglas Yee,Jeffrey S Miller.Trastuzumab and interleukin-2 in HER2-positive metastatic breast cancer: a pilot study.[J].Clinical cancer research,2003,9(7):2440-2446.

[13]Bayo-Calero Juan Lucas,Mayordomo José I,Sánchez-Rovira Pedro,Pérez-Carrión Ramón,Illaramendi José J,García-Bueno José M,González-Flores Encarnación,Crespo Carmen,Ramos-Vázquez Manuel,García-Palomo Andrés,Ruiz-Borrego Manuel,de la Haba Juan,Gómez-Bernal Amalia,Yubero-Esteban Alfonso.A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer[J].Clinical breast cancer,2008,8(3):264-268.

[14]LI Hui-ping,RAN Ran,LI Kun,KONG Wei-yao,LIU Xiao-ran,WANG Jing,ZHANG Ru-yan,SHAO Bin,YAN Ying,JIANG Han-fang,LIU Ya-xin,ZHANG Jia-yang.The primary metastatic sites in 176 patients with HER2 positive breast cancer[J].Oncology Progress,2016,14(12).

[15]Tokuda Y,Watanabe T,Omuro Y,Ando M,Katsumata N,Okumura A,Ohta M,Fujii H,Sasaki Y,Niwa T,Tajima T.Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer[J].British journal of cancer,1999,81(8):1419-1425.

[16]Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer[J].Annals of oncology

[17]Kong Sun-Young,Nam Byung-Ho,Lee Keun Seok,Kwon Youngmee,Lee Eun Sook,Seong Moon-Woo,Lee Do Hoon,Ro Jungsil.Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer[J].Clinical chemistry,2006,52(8):1510-1515.

[18]David R. Spigel,Harold J. Burstein.HER2 overexpressing metastatic breast cancer[J].Current treatment options in oncology,2002,3(2):163-174.

[19]Antonia Digklia,Ioannis A Voutsadakis.Eribulin for heavily pre-treated metastatic breast cancer patients[J].世界实验医学杂志(英文版),2015,5(3):194-199.

[20]Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France[J].Breast (Edinburgh, Scotland)